illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Medline
Company logo

Medline | Sustainability Performance

https://www.medline.com
Linkedin

Offers a comprehensive range of products and services designed to enhance patient care, improve operational efficiency and meet diverse medical needs.

1966

United States

10,001+ employees

Medical Device

$10B+ in revenue

$1B - 10B in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#2452
Overall
#519
in United States
#37
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

65 out of 175

Overview
Governance
ESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Danaher Corporation

United States, Hospital & Health Care, Medical Device


Company logo
Stryker

United States, Hospital & Health Care, Medical Device


Company logo
Becton, Dickinson & Company (BD)

United States, Hospital & Health Care, Medical Device

Market cap

42.1B $, 2026

Revenue

28.4B $, 2025▲10.3% YoY

R&D intensity

0% 2025

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Medline Industries, private US medical supplies, has faced multiple US FDA Form 483 observations at its production facilities and the historic 2023 USD 50 million CMS settlement over alleged Medicare durable medical equipment kickback allegations, plus periodic OSHA enforcement at multiple Illinois and Indiana distribution operations.
Powered by illuminem

Market cap

42.1B $, 2026▼NaN% YoY

Revenue

28.4B $, FY2025▲10.3% YoY

EBITDA

2.2B $, FY2025▼9.1% YoY

Operating margin

8% Industry: -136▼12.1% YoY

Revenue & EBITDA

$28.4BFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

1.4B 2024▲0.3% YoY

Capex

354.0M 2024▲22.3% YoY

Debt/equity ratio

1.2 Industry: 1▼NaN% YoY

R&D intensity

0.0%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

5.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

23.2

2023

25.5

2024

28.4

▲ 1.0%

2025

41.9

2030

Powered by illuminem

Overall score

0

Environment

0

Social

0

Governance

0

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees


Total sustainability employees

11+



    Available in
    Scale package

    Access
  • Email

  • Email